Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Related Keywords

United States ,Kristen Kelleher ,Kaelan Hollon ,Exchange Commission ,Trademark Office ,Provention Bio Inc ,Prnewswire Provention Bio Inc ,Twitter ,Nasdaq ,Bio Call ,Provention Bio ,United States Patent ,Senior Manager ,Nc ,